NCT01668134已完成1 期
Feasibility Study of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 28
- 试验地点
- 2
- 主要终点
- Stereotactic radiation therapy (either photon or proton) can be delivered to the liver with a less than 10% 3-month incidence of Grade 4 study related toxicity.
研究概览
简要总结
This study is being done to determine if targeted radiation therapy (stereotactic) can be given to treat liver cancer, for patient who are unable to undergo surgery, over a short period of time with a small amount of side effects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Karnofsky Performance Status of ≥ 60
- •Pathologically confirmed IHC or HCC. (Pathology not required for HCC if the lesion enhances typically on MRI and the patient is evaluated by liver transplant surgery team and thought to have HCC.)
- •4 or less separate intrahepatic lesions, with at least one lesion that is able to be followed by EASL Criteria.
- •Local surgical resection is not possible due to tumor or patient factors
- •Limited metastatic disease is allowed if the volume of metastatic disease does not exceed the volume of primary disease.
- •Prior TACE allowed if stopped/completed at least 2 weeks prior to enrollment
- •Prior chemotherapy except Sorafenib allowed if stopped/completed at least 2 weeks prior to enrollment
- •Prior Sorafenib allowed if stopped/completed at least seven days prior to enrollment.
- •Able to provide signed informed consent
排除标准
- •Childs-Pugh score 9 or more
- •ALT or AST ≥ 6 x upper limit of normal
- •Prior history of abdominal irradiation
- •Women who are pregnant or nursing
- •Scheduled to undergo chemotherapy except Sorafenib at the time when radiation therapy will be given, or for up to 4 weeks after completion of radiation therapy.
- •Scheduled to undergo Sorafenib within seven days of when radiation therapy will be delivered, or for up to 2 weeks after completion of radiation therapy.
- •Undergone prior radiation therapy to the abdomen.
结局指标
主要结局
Stereotactic radiation therapy (either photon or proton) can be delivered to the liver with a less than 10% 3-month incidence of Grade 4 study related toxicity.
时间窗: Up to 90 days after end of radiation therapy
次要结局
- Measure the response rates associated with using SBRT in patients with resectable HCC and IHC(Baseline to the first date of recurrance or progressive disease)
- Measure the overall survival rates associated with using SBRT in patients with unresectable HCC and IHC.(Baseline to time of death)
- Measure the late toxicity associated with using stereotactic radiation therapy in patients with unresectable HCC and IHC.(Up to 60 days after end of radiation therapy)
- Measure the local recurrence rates associated with using SBRT in patients with unresectable HCC and IHC.(Time of treatment until recurrance or progressive disease as measured by CT/MR from baseline to recurrance or progressive disease)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
2 期
Feasibility study of stereotactic body radiotherapy for metastatic vertebral body tumorJPRN-UMIN000013428Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital20
Unknown
2 期
Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMATProstatic NeoplasmsNCT02344667Juravinski Cancer Center40
撤回
不适用
Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerNCT02250378University of Southern California
招募中
2 期
Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver TransplantationHepatocellular CarcinomaNCT06218420Assistance Publique - Hôpitaux de Paris139
进行中（未招募）
2 期
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone SurgeryNCT03541850Jonsson Comprehensive Cancer Center92